MedPath
NMPA Approval

Dalteparin Sodium Injection

国药准字J20171061

September 25, 2017

H20170043

Drug Information

达肝素钠注射液

法安明

注射剂

0.3ml: 7500IU

化学药品

September 25, 2017

Company Information

Applicant Company

Boulevard de la Plaine 17, 1050 Bruxelles, Belgium

Manufacturing Company

Schützenstrasse 87, 99-101-88212 Ravensburg, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.